Artificial Intelligence Based Machine Learning Algorithm for Prediction of Cancer In Female Anatomy

Abstract

Breast and cervical cancers account for more than 85 percent of all cancer-related fatalities in developing nations, according to the World Cancer Research Fund. As a result, breast and cervical cancer have become one of the leading causes of mortality among women worldwide. This field is still in its infancy, with only a few studies in gynaecology and computer science looking into the detection of breast and cervical cancer. According to the researchers, medical records and early testing from individuals with breast and cervical cancer will be used in this study to determine the prognosis of those suffering from the diseases. To assess our cervical cancer predictions, we employed machine learning models such as Optimized Hybrid Ensemble Classifier (OHEC), which were trained on patient behavior and variables revealed to be associated with patient behavior. The datasets in this study have a substantial number of missing values, and the distribution of those values has been altered as a function of the missing values. OHEC classifier performance has been shown to improve when the number of features is reduced and the problem of high-class imbalance is resolved, because the accuracy, sensitivity, and specificity of the classifier, as well as the number of false positives, were used to demonstrate the success of feature selection in the suggested model's predictive analysis. This has been demonstrated through the use of numerous tests involving categorization challenges. The study underscores the critical significance of early detection and prognosis in combating breast and cervical cancers, which remain leading causes of mortality worldwide. Through the utilization of machine learning models like the OHEC, the authors have demonstrated the potential for improved predictive accuracy and clinical outcomes. The findings highlight the importance of addressing challenges such as missing data and class imbalance in enhancing the performance of predictive models for effective cancer management strategies. © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.